Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Gastroenterology Advances Basic Listing

Providing ongoing coverage of key clinical trial advances across the spectrum of gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Multivariable Model Outperforms Guideline-Based Model for Predicting CRC
05/14/2024

Jolynn Tumolo

Jolynn Tumolo
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model...
05/14/2024
Gastroenterology
News
CRC Rate Rising Among Younger Americans
05/14/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate...
05/14/2024
Gastroenterology
News
MASLD Identified as Osteoarthritis Risk Marker in US Adults
05/03/2024

Jolynn Tumolo

Jolynn Tumolo
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated...
05/03/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
04/08/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
04/08/2024
Advances in Inflammatory Bowel Disease Network
News
IBS Prevalence Slightly Above 6% in Pandemic-Era US Survey
03/28/2024

Jolynn Tumolo

Jolynn Tumolo
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed...
03/28/2024
Gastroenterology
News
H. Pylori Infection Studied for Association With Colorectal Cancer
03/12/2024

Jolynn Tumolo

Jolynn Tumolo
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter...
03/12/2024
Gastroenterology
News
Metabolic Health Does Not Protect Against Erosive Esophagitis in Adults With Obesity
03/08/2024

Jolynn Tumolo

Jolynn Tumolo
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body...
03/08/2024
Gastroenterology
News
Intrarectal Injections of BoNTA for Fecal Incontinence?
03/04/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate...
03/04/2024
Gastroenterology
News
GLP-1 Treatment Associated With Lower CRC Risk
02/27/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2...
02/27/2024
Gastroenterology
News
1 in 5 Patients with Erosive Esophagitis Cycles Through PPIs
02/23/2024

Jolynn Tumolo

Jolynn Tumolo
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump...
02/23/2024
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement